Omega Laboratories and Cannabix Technologies Announce Breath-Based DOT-Like Drug Testing Panel for Recent-Use Detection
Expanded breath-testing capability enables recent-use detection across a panel modeled after the DOT federally mandated urine drug test panel. MOGADORE, Ohio and VANCOUVER, BC, July 8, 2026 /PRNewswire/ -- Omega Laboratories, Inc. ("Omega"), and Cannabix Technologies Inc. ("Cannabix")...
Expanded breath-testing capability enables recent-use detection across a panel modeled after the DOT federally mandated urine drug test panel. MOGADORE, Ohio and VANCOUVER, BC, July 8, 2026 /PRNewswire/ -- Omega Laboratories, Inc. ("Omega"), and Cannabix Technologies Inc. ("Cannabix")...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.